| 摘要 |
<p>A pharmaceutical composition characterized by as active ingredient a combination of antiviral drugs, one of which is a quinoxaline of the formula …<CHEM>… wherein each X is separately Cl or Br and R is methyl or enthyl and the other is a hindered amine of the group consisting of cyclooctylamine, 2-aminonorbornane (i.e. 2-aminobicyclo[2.2.1]-heptane) and substituted adamantanes of the formula …<CHEM>… wherein R<1> is NH2 or CH-CH3 and R<2> is H or CH3 and excipients is useful for suppressing influenza virus infections in mammals. NH2</p> |
